NDC 0074-2600 – Mavyret
Pibrentasvir 20 mg/1; Glecaprevir 50 mg/1 · Pellet · Oral
Product NDC0074-2600
Product details
- Brand name
- Mavyret
- Generic name
- Glecaprevir and Pibrentasvir
- Labeler
- AbbVie Inc.
- Dosage form
- Pellet
- Route
- Oral
- Marketing category
- NDA · NDA215110
- Marketed since
- June 10, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Hepatitis C Virus NS3/4A Protease Inhibitor; Hepatitis C Virus NS5A Inhibitor
Active ingredients
- Pibrentasvir 20 mg/1
- Glecaprevir 50 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0074-2600-28 | 1 PACKET in 1 CARTON (0074-2600-28) / 28 PELLET in 1 PACKET | Jun 22, 2021 |
Other Mavyret products
- 0074-2625 Pibrentasvir 40 mg/1; Glecaprevir 100 mg/1 · Tablet, Film Coated · AbbVie Inc.